first glp-1 approved for weight loss FDA Approves Oral Semaglutide: Pill GLP-1R Agonists for Weight Loss

Diabetes Obes Metab (2018) 20:255764

Pfizer reported that while the overall frequency of liver enzyme elevations across the over 1,400 participant safety database of danuglipron was in line with approved agents in the class, a single asymptomatic participant in one of the dose-optimization studies experienced potential drug-induced liver injury that resolved after discontinuation of danuglipron

The offering combines virtual and in-person visits, prescription management and pharmacy fulfillment, positioning weight management as a long-term chronic condition rather than a one-off prescription

Is Exercise Still Necessary